Ask AI
JAK inhibitors in alopecia areata

CE / CME

Improving Patient Satisfaction in Alopecia Areata: Rationale and Safety Considerations for JAK Inhibitors

Nurse Practitioners/Nurses: 0.25 Nursing contact hours, includes 0.25 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Released: July 02, 2026

Expiration: July 01, 2027

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A 28-year-old patient has alopecia areata with 55% scalp hair loss, eyebrow involvement, and significant distress related to work and social interactions. Prior topical and intralesional corticosteroids were ineffective, and the patient has no major risk factors or contraindications to systemic therapy. What is the appropriate next step?

2.

How many people with alopecia areata do you provide care for in a typical month?​

3.

For those who practice in academic or community settings, please indicate your practice setting: